Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENXX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,751
Award facts
- Contract value 100% obligated
- $42,751.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $42,751.27 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 26, 2025, with an ultimate completion date of December 30, 2025, carries no set-aside designation and represents one of numerous purchase orders DMS has fulfilled through its primary contracting vehicle with DLA. The delivery order is executed under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, with performance extending through December 31, 2036.
Under the PPV-G GEN V framework—part of DLA's broader $30.3 billion pharmaceutical acquisition strategy—DMS Pharmaceutical Group supplies an extensive portfolio of pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. The vendor's product offerings encompass branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals ranging from oncology treatments to emergency medications, positioning the company as a critical supplier within the federal military medical supply chain. The delivery order is structured as firm fixed-price with no identified subcontractor relationships, enabling DLA to maintain consistent pharmaceutical supply to military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DU26FENXX?
SPE2DU26FENXX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 26, 2025.
How much is contract SPE2DU26FENXX worth?
The government has obligated $42,751 on SPE2DU26FENXX.
Is contract SPE2DU26FENXX an order under another contract?
Yes. SPE2DU26FENXX is a delivery order under SPE2DU25D9418, an indefinite delivery contract.
Was contract SPE2DU26FENXX competed?
The extent of competition for SPE2DU26FENXX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award